In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes, ...

Zhuo, C., et al. (2025). Single-cell sequencing reveals the expansion and diversity of T cell subsets in the bone marrow ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that could pave the way for a new generation of immunotherapies. Cancer ...

Cancer: «forgotten» cells go on the offensive. UNIGE Immunologists have discovered the yet unsuspected anti-tumour potential of CD4 T lymphocytes, an important step towards a ne ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

Taken together, our studies suggest that 2B010 represents an anti-CD25 mAb with unique properties in that it deleted Treg from an inflammatory ...

A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune ...

At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or school.

The same pattern held, though somewhat less dramatically, for patients beginning treatment at CD4 counts of 50–199 cells/mm 3 and 200–349 cells/mm 3; for those with baseline CD4 counts > 350 ...

CD4 T-Cell Monitoring in HIV Management. Key Themes: Immune Reconstitution: Average CD4 count increases of approximately 200 cells in the first year of effective therapy Laboratory Variability ...